Form 4 for JAGX Jaguar Health, Inc.

Accepted 2022-03-30 00:00:00 ET · period of report 2021-09-13 · accession 0001104659-22-040397 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DI	2022-03-30	2021-09-13	JAGX	Lizak Carol R.	CFO	P - Purchase	$2.51	+7,968	7,968	New	+$20.0K
D	2022-03-30	2022-03-28	JAGX	Lizak Carol R.	CFO	A - Grant	$0.00	+97.0K	97.0K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2021-09-13	P	A	7,968	$2.51	7,968	I See Footnote	—	—	(F1) Securities held directly by the Peter & Carol Lizak Revocable Trust. Ms. Lizak, by virtue of her position as a co-trustee and beneficiary of such trust and her sharing of voting and investment control over the securities held by the trust with her spouse, may be deemed to beneficially own the securities held by the Peter & Carol Lizak Trust for purposes of Section 16.
2	Derivative	Restricted stock units	2022-03-28	A	A	97,025	$0.00	97,025	D	— · — to —	97,025 Common Stock	(F2) Granted pursuant to the issuer's 2014 Stock Incentive Plan. (F4) The restricted stock unit grants were approved by the issuer's board of directors on March 28, 2022. (F3) Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. (F5) The restricted stock units vest in three equal annual installments beginning on May 17, 2023. Vested shares will be delivered to the reporting person on the vesting date provided in the grant notice.